News | May 01, 2025
Aster DM Healthcare completes acquisition of 5% stake in Quality Care India
The transaction structured as share swap, is valued at ~Rs. 849 crore, with no cash outflow
The transaction structured as share swap, is valued at ~Rs. 849 crore, with no cash outflow
This approval authorizes the company to export Ibuprofen to the Chinese markets
Delivers robust earnings performance, successfully navigating a dynamic environment
The positive opinions are based on applications submitted by Biosimilar Collaborations Ireland Limited
Bayer expects 2025 to be the most difficult year of its turnaround
Durable pain relief from a single MM-II injection and its cartilage-protective effects in OA modelsfeatured in two peer-reviewed articles
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
The company delivered revenues of Rs. 5,554 crore, representing 10% growth in FY25
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
The merged entity ‘Aster DM Quality Care’ will be jointly controlled by Aster Promoters and Blackstone
Subscribe To Our Newsletter & Stay Updated
